EGFR and squamous cell carcinoma: Overexpression of epidermal growth factor receptor (EGFR) occurs in approximately 80% of patients with adenocarcinoma and squamous cell carcinoma [42], and many studies have demonstrated that overexpression of EGFR is associated with a lower survival rate [43, 44].